DRAP permits clinical trials of plasma therapy for treatment of COVID-19: Dr Mirza

Special Assistant to the Prime Minister on National Health Services, Dr. Zafar Mirza has said Drug Regulatory Authority of Pakistan has allowed the local production of raw material of cholorquine as part of efforts to cope with coronavirus challenge.   

In a statement today, he said the DRAP has also permitted clinical trials of plasma therapy for COVID-19 treatment.

The Special Assistant said the drug regulatory body has also allowed the clinical trials of locally manufactured ventilators.

More than fifty companies have been allowed to produce sanitizers to contain the spread of the pandemic.

The companies will prepare quality sanitizers as per the directions of the World Health Organization.      

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *